New articles and mentions:
- European Medicines Agency (EMA) and its Paediatric Committee (PDCO) letter of support for the ACCELERATE FAIR (Fostering Age Inclusive Research) Working Group.
- Considerations for the Inclusion of Adolescent Patients in Adult Oncology Clinical Trials Guidance for Industry: March 2019
- de Rojas, T., Neven, A., Garcia-Abos, M., Moreno, L., Gaspar, N., & Peron, J. (2019). The 18-year-old clinical trial inclusion limit is a major barrier in the access to immunotherapies and targeted therapies for adolescents and young adults (AYAs) with cancer. Annals Of Oncology, 30(Supplement_1). doi: 10.1093/annonc/mdz026
- Analysis Compares the Rates of Access of Adolescents and Young… | ESMO. (2019)
- Audiocast: Proffered Paper session 1 | OncologyPRO. (2019).
- ‘Paediatric oncology: Equal access to childhood cancer medicines’, SciTech Eurpoa, February 2019
- ‘4 ways cancer is changing how we test medicines’
- ‘ACCELERATE-ing access to drugs for adolescents with cancer’
- ‘Tragedy of children dying from cancer because drug companies won’t include them in trials’
- ‘FDA Calls for Including Adolescents in Adult Oncology Trials’
- ‘Horizon: Teenagers vs Cancer: a User’s Guide, review – this film strove to be cheerful but was hampered by lack of clinical trials’
Recent BBC Horizon programme, ‘Teenagers vs. Cancer.’ This clip focuses on the age issue and features Debbie Binner speaking about her daughter, Chloe:
— BBC Two (@BBCTwo) June 28, 2018